Selective T Cell Costimulation Modulator [EPC]

76378 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 25130
1 RHEUMATOID ARTHRITIS 12193
2 PAIN 8289
3 CONTRAINDICATED PRODUCT ADMINISTERED 7164
4 ARTHRALGIA 6279
5 DRUG INTOLERANCE 6233
6 JOINT SWELLING 5764
7 OFF LABEL USE 5338
8 FATIGUE 5327
9 TREATMENT FAILURE 5009
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 267 0.9303
1 RHEUMATOID FACTOR NEGATIVE 113 0.7847
2 RED BLOOD CELL SEDIMENTATION RATE 76 0.7037
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 28 0.6829
4 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1026 0.6577
5 RHEUMATOID FACTOR POSITIVE 920 0.6137
6 ATLANTOAXIAL INSTABILITY 52 0.5909
7 PEMPHIGUS 1631 0.5846
8 C-REACTIVE PROTEIN ABNORMAL 1475 0.5793
9 JOINT LAXITY 114 0.5758
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]